CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $151.89M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 4.89: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
216.47BKRW151.89M · vs all stocks (USD)
Revenue (TTM)
14.15BKRW9.93M · vs all stocks (USD)
Profit Margin
-53.42%Beta
1.83xvs all stocks
52-Week Change
-64.05%vs all stocks
Market Capitalization
216.47BKRW151.89M · vs all stocks (USD)
Enterprise Value
281.54BKRW197.55M · vs all stocks (USD)
Price to Sales (TTM)
14.25xPrice to Book (MRQ)
1.43xEnterprise to Revenue
19.89xEnterprise to EBITDA
-45.18xGross Margin
45.81%Profit Margin
-53.42%Operating Margin
1.57%Return on Assets (TTM)
-11.71%Return on Equity (TTM)
-39.82%Revenue (TTM)
14.15BKRW9.93M · vs all stocks (USD)
Revenue per Share (TTM)
1.08KKRWUpdated Jul 14, 2026Quarterly Revenue Growth
89.50%Gross Profit (TTM)
1.10BKRW774.22K · vs all stocks (USD)
EBITDA (TTM)
9.24BKRW6.48M · vs all stocks (USD)
Net Income (TTM)
-7.56BKRW-5.30M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-54.10%Operating Cash Flow (TTM)
-482.29MKRW-338.41K · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-1.22BKRW-858.77K · vs all stocks (USD)
Payout Ratio
0.00%Revenue
205.58BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
99.08BKRWFY2025 · Dec 31, 2025Gross Profit
106.50BKRWFY2025 · Dec 31, 2025Operating Income
1.06BKRW746.44K · vs all stocks (USD)
Pre-tax Income
4.99BKRWFY2025 · Dec 31, 2025Income Tax Expense
414.02MKRWFY2025 · Dec 31, 2025Net Income
4.57BKRWFY2025 · Dec 31, 2025EBIT
5.72BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
9.68BKRWFY2025 · Dec 31, 2025Research & Development
3.34BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
93.08BKRWFY2025 · Dec 31, 2025Other Operating Expenses
422.50MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
654.90MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
738.08MKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
4.57BKRWFY2025 · Dec 31, 2025Operating Cash Flow
209.04MKRWFY2025 · Dec 31, 2025Free Cash Flow
-6.90BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
7.61BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
4.57BKRWFY2025 · Dec 31, 2025Stock-based Compensation
173.44MKRWFY2025 · Dec 31, 2025Other Non-cash Items
-2.07BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.22BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.69BKRWFY2025 · Dec 31, 2025Capital Expenditures
-7.11BKRWFY2025 · Dec 31, 2025Net Acquisitions
-4.00BKRWFY2025 · Dec 31, 2025Purchase of Investments
-23.56BKRWFY2025 · Dec 31, 2025Sale of Investments
30.79BKRWFY2025 · Dec 31, 2025Other Investing Activity
-17.45BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-21.32BKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
19.04BKRWFY2025 · Dec 31, 2025Shares Outstanding
32.80MSharesUpdated Jul 14, 2026Float Shares
26.93MSharesUpdated Jul 14, 2026% Held by Insiders
20.93%vs all stocks
% Held by Institutions
0.47%vs all stocks
Total Cash (MRQ)
19.87BKRW13.94M · vs all stocks (USD)
Total Cash per Share (MRQ)
605.82KRWUpdated Jul 14, 2026Total Debt (MRQ)
20.32BKRW14.26M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1339xCurrent Ratio (MRQ)
1.55xBook Value per Share (MRQ)
4.63KKRWUpdated Jul 14, 2026Total Assets
170.68BKRW119.76M · vs all stocks (USD)
Total Current Assets
76.70BKRWFY2025 · Dec 31, 2025Total Liabilities
45.53BKRWFY2025 · Dec 31, 2025Total Non-current Assets
93.98BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
5.91BKRWFY2025 · Dec 31, 2025Total Current Liabilities
39.63BKRWFY2025 · Dec 31, 2025Cash
7.61BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
7.61BKRWFY2025 · Dec 31, 2025Other Short-term Investments
14.53BKRWFY2025 · Dec 31, 2025Accounts Receivable
22.83BKRWFY2025 · Dec 31, 2025Inventory
29.53BKRWFY2025 · Dec 31, 2025Accounts Payable
10.26BKRWFY2025 · Dec 31, 2025Short-term Debt
16.54BKRWFY2025 · Dec 31, 2025Other Current Liabilities
-130.00KRWFY2025 · Dec 31, 2025Long-term Debt
4.14BKRWFY2025 · Dec 31, 2025Common Stock (Book)
16.40BKRWFY2025 · Dec 31, 2025Retained Earnings
56.37BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
125.15BKRW87.81M · vs all stocks (USD)
Treasury Stock
5.60MKRWFY2025 · Dec 31, 202552-Week Low
6.00KKRWUpdated Jul 14, 202652-Week High
22.25KKRWUpdated Jul 14, 202652-Week Change
-64.05%vs all stocks
Beta
1.83xvs all stocks
50-Day MA
13.05KKRWUpdated Jul 14, 2026200-Day MA
15.25KKRWUpdated Jul 14, 2026Avg 10-Day Volume
149.23KSharesUpdated Jul 14, 2026Avg 30-Day Volume
134.54KSharesUpdated Jul 14, 2026Diluted EPS (TTM)
140.00KRWUpdated Jul 14, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.46Profit Margin: -0.53
Financial Health
Altman Z-Score 4.89: safe zoneNotable
Altman Z-Score: 4.89
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $151.89M, lower than 95% of all stocks globallySignificant
Market cap (USD): 151,889,683.879Global P5: 269,387,740.27
Revenue is $9.93M, lower than 95% of all stocks globallySignificant
Revenue (USD): 9,929,729.58Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Yungjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
EKF Diagnostics Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Enlivex Therapeutics Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
S Biomedics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Chill Brands Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
Graphy Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sensorion SA
Tier 1ProductionApproval-Gated PipelineRuleRisk
Mycenax Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Journey Medical Corp
Tier 1ProductionApproval-Gated PipelineRule
Alector Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Eos Energy Enterprises Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Defi Technologies Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Doximity Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated